v3.25.2
Consolidated Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Ordinary Shares
Class A
Ordinary Shares
Class B
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 [1] $ 460 $ 24,540 $ (46,877) $ (21,877)
Balance (in Shares) at Dec. 31, 2022 [1] 4,600,000      
Net income (loss) (41,692) (41,692)
Balance at Dec. 31, 2023 [2] $ 460 24,540 (88,569) (63,569)
Balance (in Shares) at Dec. 31, 2023 [2] 4,600,000      
Sale of 509,000 Private Placement Shares $ 51 5,089,949 5,090,000
Sale of 509,000 Private Placement Shares (in Shares) 509,000      
Allocated value of transaction costs to private shares (22,096) (22,096)
Share-based compensation expense 39,372 39,372
Accretion of Class A ordinary shares subject to possible redemption (5,131,765) (4,233,488) (9,365,253)
Net income (loss) 1,100,442 1,100,442
Balance at Mar. 31, 2024 [3] $ 51 $ 460 (3,221,615) (3,221,104)
Balance (in Shares) at Mar. 31, 2024 [3] 509,000 4,600,000      
Balance at Dec. 31, 2023 [2] $ 460 24,540 (88,569) (63,569)
Balance (in Shares) at Dec. 31, 2023 [2] 4,600,000      
Sale of 509,000 Private Placement Shares $ 51 5,089,949 5,090,000
Sale of 509,000 Private Placement Shares (in Shares) 509,000        
Allocated value of transaction costs to private shares (22,096) (22,096)
Share-based compensation expense 271,572 271,572
Accretion of Class A ordinary shares subject to possible redemption (5,363,965) (11,244,064) (16,608,029)
Net income (loss) 7,599,512 7,599,512
Balance at Dec. 31, 2024 [2] $ 51 $ 460 (3,733,121) (3,732,610)
Balance (in Shares) at Dec. 31, 2024 [2] 509,000 4,600,000      
Share-based compensation expense 57,919 57,919
Accretion of Class A ordinary shares subject to possible redemption (57,919) (1,931,349) (1,989,268)
Net income (loss) (487,392) (487,392)
Balance at Mar. 31, 2025 $ 51 $ 460 $ (6,151,862) $ (6,151,351)
Balance (in Shares) at Mar. 31, 2025 509,000 4,600,000      
[1] Includes an aggregate of up to 600,000 Class B ordinary shares that are subject to forfeiture depending on the extent to which the underwriter’s over-allotment option is exercised. On February 13, 2024, simultaneously with the closing of the Initial Public Offering, the underwriter fully exercised its over-allotment option, and accordingly, the 600,000 Founder Shares are no longer subject to forfeiture (Note 5).
[2] On February 1, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 1,437,500 Class B ordinary shares, resulting in a total of 4,312,500 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor. On February 8, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 287,500 Class B ordinary shares, resulting in a total of 4,600,000 Class B ordinary shares held by the Sponsor and the Company’s two independent directors and one advisor.
[3] On February 1, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 1,437,500 Class B ordinary shares, resulting in a total of 4,312,500 Class B ordinary shares held by the Sponsor and Company’s two independent directors and one advisor. On February 8, 2024, the Company effected a share capitalization with respect to the Class B ordinary shares of 287,500 Class B ordinary shares, resulting in a total of 4,600,000 Class B ordinary shares held by the Sponsor and Company’s two independent directors and one advisor.